Written questions by Cordova.

How many outpatient paediatric ophthalmology appointments for children under 19 years were (a) cancelled and (b) missed because the patient did not attend in 2023-24.

Patients awaiting outpatient care make up over 85% of the elective waiting list, which includes children. Minimising missed appointments will help us to make sure we maximise the use of clinical time and ensure that all patients can be seen sooner. This is part of delivering on our commitment that 92% of patients, including children awaiting hospital-based eyecare, return to waiting no longer than 18 weeks from Referral to Treatment.The following table shows the recorded outcomes of outpatient paediatric ophthalmology appointments in 2023/24, for children aged zero to 18 years old:OutcomeAppointmentsCancelled by hospital69,335Cancelled by patient61,699Did not attend61,904Not known/other221Attended377,520Source: Hospital Episode Statistics, NHS England.No estimate has been made of the cost of missed appointments to outpatient paediatric ophthalmology because the Department does not hold information centrally on the extent to which outpatient clinics are overbooked based on the expectation that some appointments will be cancelled or marked as did not attend, and that clinicians may undertake other clinical work during these missed clinic appointments.

If he will require NHS England to publish Referral To Treatment waiting times for (a) glaucoma, (b) macular degeneration and (c) other irreversible sight loss conditions separately from minor and reversible eye condition waiting times.

There are no current plans to require NHS England to publish Referral to Treatment waiting times for glaucoma, macular degeneration, and other irreversible sight loss conditions separately from minor and reversible eye condition waiting times.

What steps his Department is taking to improve the (a) assessment of and (b) access to specialist treatments for rare diseases.

The Government is committed to improving the lives of those living with rare diseases. The UK Rare Diseases Framework sets out four priorities collaboratively developed with the rare disease community, including improving access to specialist care, treatments, and drugs. We remain committed to delivering under the framework, and will publish an England action plan in 2025. Delivery partners have committed to reviewing the effectiveness of treatment access pathways like the Early Access to Medicines Scheme (EAMs), the Innovative Licensing and Access Pathway (ILAP), and the Innovative Medicines Fund for rare disease therapies.NHS England commissions over 80 highly specialised services provided to small numbers of patients, which includes services for rare diseases. The services are delivered and co-ordinated nationally through a limited number of expert centres, to develop appropriate clinical quality, expertise, and experience.The Medicines and Healthcare products Regulatory Agency supports development and access to treatments for rare diseases through regulating the medicines supplied in the United Kingdom. These include the Orphan Medicinal Products Regulation, and Marketing Authorisations under Exceptional Circumstances for treatments where there is limited data, such as rare diseases. Additionally, initiatives like Project Orbis, the ILAP, the EAMS, and the Regulatory Advice Service for Regenerative Medicines accelerate access to treatments.The National Institute for Health and Care Excellence (NICE) makes recommendations for the National Health Service on whether all licensed new medicines should be routinely funded by the NHS, based on an assessment of their costs and benefits. The NHS in England is legally required to fund medicines recommended by the NICE, normally within three months of the publication of final guidance. The NICE operates a separate Highly Specialised Technologies (HST) programme for very rare diseases, with significantly higher cost-effectiveness thresholds than those evaluated under the NICE’s standard technology appraisal processes. Decisions on whether new medicines should be evaluated through the HST programme are taken by the NICE against published routing criteria.

What steps his Department is taking to ensure that patients living with rare inherited retinal diseases receive (a) timely and (b) equitable access to new treatments.

The Government is committed to improving the lives of those living with rare diseases, such as rare inherited retinal diseases. The UK Rare Diseases Framework sets out four priorities collaboratively developed with the rare disease community, including improving access to specialist care, treatments, and drugs. We remain committed to delivering under the framework, and will publish an England action plan in 2025.The National Institute for Health and Care Excellence (NICE) makes recommendations for the National Health Service on whether all licensed new medicines should be routinely funded by the NHS based on an assessment of their costs and benefits, and NHS England ensures that funding is available for any licensed new medicines recommended by the NICE. The NICE aims to issue guidance on new medicines, including for rare diseases, as close to the time of licensing as possible. The NICE operates a separate Highly Specialised Technologies (HST) programme for very rare diseases, with significantly higher cost-effectiveness thresholds than those evaluated under the NICE’s standard technology appraisal processes. Decisions on whether new medicines should be evaluated through the HST programme are taken by the NICE against published routing criteria.The NICE is currently appraising one treatment for treating visual impairment caused by a rare inherited retinal disease, and final guidance is expected to be published in April 2025.

Whether she has had discussions with the Mayor of London on the potential merits of connecting Clapham Junction station to the Northern line.

Government remains committed to supporting London and the transport network on which it depends. We recently provided £485m in funding to support Transport for London’s (TfL) capital programme for 2025/26 and will continue to work with TfL to understand its capital funding needs, which will be considered at Phase 2 of the Spending Review. However, transport in London is devolved to the Mayor of London and TfL and it is for the Mayor to assess the merits of capital projects and make decisions on investment.

What steps she plans to take to tackle disproportionate use of full strip searches during stop and searches of (a) Black, (b) Asian and (c) other ethnic minority people.

Strip search is one of the most intrusive powers available to the police and its use must be fair, respectful and without unlawful discrimination. No one should be subject to the use of any police power based on their race or ethnicity. That is why the Government’s manifesto committed to introducing new legal safeguards around strip-searching children and young people.This Government welcomes the recent reduction in the disproportionate use of stop and search powers, but there is more work to do. We are also increasing transparency in the use of these powers. Figures published in September, covering the 12 months to March 2024 includes, for the first time, data on whether the stop and search included a strip search.

Whether she plans to consult organisations led by disabled people on an accessibility road map for rail travel.

Ensuring accessibility for all passengers is at the heart of the Government’s passenger-focussed approach. We know that the experience for disabled people when traveling on rail too often falls short of what is expected and what passengers deserve. We are committed to improving the experience for disabled passengers and have committed to publishing an accessibility roadmap to explain the actions we are taking to improve accessibility ahead of GBR. We are working to define the approach to development of the roadmap, but I confirm we will engage with disabled people and key organisations, in line with our commitment in the House of Lords as part of the debate on the Passenger Railway Services (Public Ownership) Act, in order to ensure that it addresses the issues and needs of passengers who require assistance.

Whether her Department plans to consult organisations led by disabled people on the reforms set out in the Get Britain Working White Paper.

The Government is committed to working in partnership with disabled people and the organisations that represent them. Following on from the publication of the Get Britain Working White Paper, we will establish a disability panel to ensure that disabled people’s views and voices are at the heart of the design and delivery of our employment reforms. We will carry out in-depth consultations to seek input and expertise from a wide range of stakeholders including disabled people, community groups and employers.

Commonwealth and Development Affairs, if he will conduct a further review with Cabinet colleagues into the compatibility of the Government's export licences to Israel with its obligations under international humanitarian law in the context of recent civilian deaths in (a) Lebanon, (b) the West Bank and (c) Gaza; and if he will make a statement.

The International Humanitarian Law (IHL) Cell undertakes regular assessments of Israel's commitment and capability to comply with International Humanitarian Law in order to meet our legal obligations under the Strategic Export Licensing Criteria (SELC). On 2 September, following a conclusion that there is a clear risk that items might be used to commit or facilitate serious violations of IHL, we suspended relevant export licences to Israel for use in military operations in Gaza. This is subject to the specific measures set out to Parliament excluding exports to the global F-35 programme from the scope of the suspension. We continue to keep all export licences under careful review and licences may be suspended, amended or revoked.

Commonwealth and Development Affairs, what steps he is taking to encourage the Israeli authorities to help protect rescue workers in the Middle East.

We continue to press Israel to do more to protect civilians, aid and health workers in Gaza. Israel must comply with international law. We call on Israel to co-operate fully with humanitarian agencies, to make provisions for humanitarians to carry out their work safely and effectively. Restricting their work is unacceptable. The Minister for the Middle East raised concerns about hospitals and healthcare workers coming under fire with the Israeli Ambassador on 5 November.

Media and Sport, what assessment she has made of the (a) effectiveness of the Listed Places of Worship Grant Scheme and (b) potential impact of that scheme on local cultural heritage in areas of low economic activity.

The Department continues to monitor the Listed Places of Worship grant scheme through the regular reporting of the grant administrator, EMB. Since 2010, the Government has returned over £350 million to listed churches, synagogues, mosques and temples through the grant scheme continuing their work as centres of worship and community assets, in places all over the country, including areas of low economic activity.

What assessment she has made of the potential impact of changes to ticket office opening hours at Southeastern railway stations on commuters; and what steps her Department is taking to increase accessibility to ticket offices for disabled passengers across the rail network.

Southeastern ticket office changes were agreed under the previous Government. The Department is now examining these plans to ensure passengers remain supported.We recognise the vital role ticket offices play in the journeys of people with disabilities, and ensuring accessibility for all passengers is at the heart of our passenger-focused approach.

Pursuant to the Answer of 2 September 2024 to Question 2469 on Health Services: Disability, when he expects NHS England's review of the Accessible Information Standard to be published.

We understand how vital it is to ensure that the communication needs of patients and carers with a disability, impairment or sensory loss are met by health services. A revised AIS is being reviewed with a view to publication once it has been through NHS England’s internal assurance and governance processes. NHS England are also working on ensuring accessible versions are available at the point of publication.While we do not yet have a confirmed publication date, the current AIS remains in force and therefore, there should not be a gap in provision for people using services. NHS England is also continuing to work to support implementation of the AIS with awareness raising, communication and engagement, and a review of the current e-learning modules on the AIS.

If she will make an assessment of the potential merits of (a) creating a Gaza Family visa scheme modelled on the Ukraine Family Scheme visa and (b) deferring biometric requirements for those eligible for family reunion but unable to leave Gaza.

The Government is determined to secure a ceasefire in Gaza and rapidly increase aid, ensuring humanitarian support is reaching people there. The government is keeping existing visa pathways under review in response to events. Palestinian nationals who wish to come to the UK can do so via the existing range of routes available. Immediate family members of British citizens and those settled in the UK who wish to come and live in the UK can apply under one of the existing family visa routes. The FCDO is also providing consular assistance to those with British nationality, or dual nationality including British, who are in Gaza or who have left Gaza to a third country. Any application for a UK visa will be assessed against the requirements of the Immigration Rules.Biometrics, in the form of fingerprints and facial images, underpin the UK immigration system and are integral to national security. We recently published updated guidance on Gov.UK that sets out the circumstances where we may predetermine an application before a person attends a visa application centre to enrol their biometric information or when we may excuse the person from having to enrol their biometrics before they travel to the UK. Where a relevant application is made, consideration will be given to compelling compassionate factors that are raised.

Communities and Local Government, if she will take steps to raise the default minimum accessibility requirement to the M4(2) Accessible and Adaptable standard for all new residential buildings.

I understand that accessibility in new homes, and accessibility standards for buildings in general, are an important concern. Housing is one of this Government’s top priorities, everyone deserves to live in a decent home in which they feel safe. We will set out our policies on accessible new build housing shortly.

When her Department plans to announce stations that have been selected for Access for All Control Period 7 funding.

We are carefully considering the best approach to the Access for All programme. This Government is committed to improving the accessibility of the railway and recognises the social and economic benefits this brings to communities.

With reference to the Scope report entitled Disability Price Tag 2024, what steps she is taking to support disabled households with extra costs.

Personal Independence Payment (PIP) provides a contribution to the extra costs that may arise from a disability or health condition. There is no objective way of deciding what an adequate level of PIP should be, as everyone has different requirements reflecting their own circumstances and priorities. PIP is a non-contributory, non-means-tested, additional cost benefit and can be worth over £9,500 a year, tax free. Individuals can choose how to use the benefit, in the light of their individual needs and preferences. The benefit can also be paid in addition to any other financial or practical support someone may be entitled to such as Universal Credit, Employment and Support Allowance, NHS services, free prescriptions, help with travel costs to appointments or the Blue Badge scheme. The benefits have been consistently uprated in line with inflation since they were introduced and were, like other benefits, increased by 6.7% from 8 April 2024. DWP pays close attention to the evidence base on the extra costs faced by disabled people; including academic research, analysis by Scope, and DWP’s own commissioned research on the Uses of Health and Disability Benefits from 2019. In order to understand more, DWP is now undertaking a new a survey of Personal Independence Payment customers to understand more about their disability related needs. This project has an advisory group of experts including representatives of the disability charity Scope, academic experts, and Disability Rights UK.

With reference to the Scope report entitled Disability Price Tag 2024, published in September 2024, what assessment she has made of the potential implications for her policies of extra costs incurred by disabled people.

Personal Independence Payment (PIP) provides a contribution to the extra costs that may arise from a disability or health condition. There is no objective way of deciding what an adequate level of PIP should be, as everyone has different requirements reflecting their own circumstances and priorities. PIP is a non-contributory, non-means-tested, additional cost benefit and can be worth over £9,500 a year, tax free. Individuals can choose how to use the benefit, in the light of their individual needs and preferences. The benefit can also be paid in addition to any other financial or practical support someone may be entitled to such as Universal Credit, Employment and Support Allowance, NHS services, free prescriptions, help with travel costs to appointments or the Blue Badge scheme. The benefits have been consistently uprated in line with inflation since they were introduced and were, like other benefits, increased by 6.7% from 8 April 2024. DWP pays close attention to the evidence base on the extra costs faced by disabled people; including academic research, analysis by Scope, and DWP’s own commissioned research on the Uses of Health and Disability Benefits from 2019. In order to understand more, DWP is now undertaking a new a survey of Personal Independence Payment customers to understand more about their disability related needs. This project has an advisory group of experts including representatives of the disability charity Scope, academic experts, and Disability Rights UK.

What steps her Department is taking to collaborate with (a) disabled people and (b) disabled people's organisations to help improve disabled people's interactions with the benefits system.

This Government is committed to championing the rights of disabled people and to the principle of working with them, so that their views and voices will be at the heart of all that we do. The Health Transformation Programme (HTP) is modernising health and disability benefit services to improve user experience and increase trust in these services. HTP service design has been informed by user research conducted with customers, operational staff and health care professionals, including one-to-one sessions with customers at each stage of their claim. The Department has also engaged with a significant number of stakeholder organisations, establishing positive relationships with representative groups by seeking their expertise before beginning to develop and test new processes. This collaborative approach will help the department to tailor services to customer needs.

Pursuant to the Answer of 2 August 2024 to Question 1798 on Work Capability Assessment, what steps she is taking to (a) reform or (b) replace the Work Capability Assessment.

The government is committed to reforming or replacing the Work Capability Assessment, alongside putting in place a proper plan to support disabled people into work. We will say more about this in due course. We will continue to engage with stakeholders to keep the views of disabled people and people with health conditions at the heart of what we do, as we consider our next steps.